Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Abstract Background Polypharmacy is associated with poorer health outcomes in older adults. Other than the associated multimorbidity, factors contributing to this association could include medication adverse effects and interactions, difficulties in managing complicated medication regimes, and reduc...

Full description

Bibliographic Details
Main Authors: Dee Mangin, Larkin Lamarche, Gina Agarwal, Abbas Ali, Alan Cassels, Kiska Colwill, Lisa Dolovich, Naomi Dore Brown, Barbara Farrell, Karla Freeman, Kristina Frizzle, Scott R. Garrison, James Gillett, Anne Holbrook, Jane Jurcic-Vrataric, James McCormack, Jenna Parascandalo, Julie Richardson, Cathy Risdon, Diana Sherifali, Henry Siu, Sayem Borhan, Jeffery A. Templeton, Lehana Thabane, Johanna Trimble
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Pilot and Feasibility Studies
Subjects:
Polypharmacy
Deprescribing
Multi-morbidity
Patient safety
Primary care
Online Access:https://doi.org/10.1186/s40814-023-01315-0

Internet

https://doi.org/10.1186/s40814-023-01315-0

Similar Items